INTRODUCTION
Small GTPases of the Rho family play a pivotal role in the regulation of a variety of cellular functions including the organization of the actin cytoskeleton [1] , cell cycle progression [2, 3] , cell adhesion [4] [5] [6] , tumor progression [7] [8] [9] and gene expression [10, 11] . Since Ras/Rho GTPases need C-terminal isoprenylation for correct intracellular localization and function, it is assumed that part of the biological effects of HMG-CoA reductase inhibitors (i.e. statins) is due to inhibition of Ras/Rho function [12] [13] [14] . Recently we showed that activation of stress inducible signal mechanisms including the stimulation of c-Jun N-terminal kinases / stress activated protein kinases (JNK/SAPK) and NF-κB is impaired by the HMG-CoA reductase inhibitor lovastatin [12, 15] .
It is well established that the expression of various cell adhesion molecules is regulated by the transcription factor NF-κB [16] . NF-κB becomes activated not only by inflammatory cytokines but also by genotoxic agents such as ionizing radiation (IR) and others [17, 18] . Therefore, it is tempting to speculate that, beside inflammatory cytokines, IR is also able to increase the expression of cell adhesion molecules. In line with this, IR has been demonstrated to induce the expression of ICAM, VCAM and E-selectin [19] [20] [21] . Notably, IR stimulates E-selectin expression much stronger than the expression of ICAM-1 [22] . Inhibition of NF-κB by overexpression of dominant-negative construct blocks ICAM-1 and E-selectin gene induction by IR [22] . Radiation-provoked increase in the expression of cell adhesion molecules was also observed in vivo, both in rodent lung [23] and in human skin [19] . An increased expression of cell adhesion molecules on endothelial cells promotes the adhesion of leukocytes and is therefore believed to be the molecular basis of inflammation provoked as a side effect of radiation therapy. In line with this, E-selectin was reported to be essential for the enhanced adhesion of leukocytes to irradiated vascular endothelium [24] . The anti-inflammatory effect of low radiation dose (i.e. 0.3-0.6 Gy) was ascribed to the attenuation of cytokine-triggered expression of E-selectin [21, 25] .
Beside its well known contribution to inflammatory responses, E-selectin also plays a central role in the process of metastasis by promoting the adhesion of circulating tumor cells to the endothel [26] , which is a prerequisite for their extravasation. The correlation of the expression of E-selectin and tumor specific expressed ligands for E-selectin (i.e. sialyl-LewisX or sialylLewisA) with the metastatic potential of malignant cells has been most convincingly demonstrated for colon carcinoma cells [27] [28] [29] [30] [31] . Thus, overall, expression of E-selectin can be considered as one important factor promoting metastasis.
Bearing this in mind, we wished to clarify whether radiation treatment is able to affect the level of tumor cell adhesion to the endothel. To our best knowledge this aspect of a putative side effect of radiation treatment has not yet been considered so far. The present study aimed at characterizing the effect of IR on E-selectin expression and tumor cell adhesion to the endothel and furthermore addressed the questions as to (i) the involvement of Rho GTPases in the regulation of IR-induced expression of E-selectin and (ii) whether IR-stimulated Eselectin expression and tumor cell adhesion might be blocked by clinically established pharmaceuticals. 
MATERIALS AND METHODS

Materials
Lovastatin was purchased from Calbiochem-Novabiochem (Bad Soden, Germany). Oligonucleotides originate from Sigma-Aldrich Fine Chemicals (Taufkirchen, Germany). Clostridium difficile toxin A (ToxA) was a gift from I. Just (Institute of Toxicology, Hannover, Germany). 9-cis retinoic acid and all-trans retinoic acid were purchased from ICN Biomedicals GmbH (Eschwege, Germany). Anti-E-selectin, anti-P-selectin and ERK2 antibodies used in this study were purchased from Santa Cruz Biotechnology Inc. (Heidelberg, Germany), antibody directed against ICAM-1 was from R&D Systems GmbH (Wiesbaden-Nordenstadt, Germany) POD-conjugated anti-mouse antibody used for ELISAanalyses was obtained from Promega Corporation (Mannheim, Germany). Phospho-specific IκBα antibody was purchased from New England Biolabs GmbH (Frankfurt am Main, Germany). For treatment of cells with ionizing radiation (i.e. γ-rays), a 60 Co source (Atomic Energy of Cananda Ltd.) was used. The Titan One Tube RT-PCR Kit originates from Roche Diagnostics GmbH (Mannheim, Germany). For cloning of the E-selectin promoter PowerScript DNA Polymerase was used (PAN TM Biotech GmbH, Aidenbach, Germany). Luciferase activity was determined by use of the Luciferase assay system (Promega Corporation, Mannheim, Germany). CDNAs and epression vectors for dominant negative Rho GTPases (N17Rac and N19RhoB) are described elswhere [32] . Dominant-negative RhoA (N19Rho) originates from A. Hall (University College London, UK). The cell line EA.hy-926 was obtained from Cora-Jean S. Edgell (University of North Carolina, USA). Human umbilical vein endothelial cells (HUVEC) were purchased from Cambrex (BioWhittaker Europe, Verviers, Belgium).
Cell culture conditions EA.hy-926 cells and human colon carcinoma cells (DLD1) (originating from the American Type Culture Collection (ATCC)) were grown in Dulbeccos medium containing 10% heat inactivated fetal bovine serum (FBS). EA.hy-926 culture medium additionally contains 1% HAT media supplement. Human umbilical vein endothelial cells (HUVEC) were cultured using endothelial cell growth media system (EGM-2) from Cambrex (BioWhittaker Europe,Verviers, Belgium) containing 2% fetal calf serum (FCS) according to the manufacturer´s protocol. HUVEC were used in the fourth to sixth passage for experiments.
Western blot analysis
To detect activation of NF-κB signaling pathway, phosphorylation of the inhibitory molecule IκBα was measured by Western blot analysis using phospho-specific IκBα antibody (detecting IκBα phosphorylated on Ser32). 15 min after irradiation, cells were harvested and 30 µg of protein was separated by polyacrylamide gel electrophoresis (10 % denaturing gels). After transfer of the proteins to nitrocellulose, membrane was blocked (5 % dry milk in PBS/0.1 % tween, 2h, RT), before overnight incubation with phospho-specific antibody (1:1000) according to the manufacturers protocoll. After washing and incubation with peroxidase-coupled secondary anti-rabbit antibody, phosphorylated IκBα was visualized by chemiluminescence.
ELISA analysis
For quantitation of E-selectin protein expression an ELISA-based method was used. To this end, 4x10 4 endothelial cells were seeded into 96-well microtitre plates and grown overnight. Before pretreatment and stimulation of the cells the medium was replaced. About 5h after stimulation, plates were stored on ice for 10 min. Afterwards the cell layer was washed twice at Pennsylvania State University on February 21, 2013 http://carcin.oxfordjournals.org/ Downloaded from with ice-cold PBS/1% BSA. Cells were incubated with anti-E-selectin antibody for 90 min (1:50 in PBS/1%BSA). After washing (3x), POD-conjugated secondary antibody (1:1000 in PBS/1%BSA) was added for 60 min. All steps were performed on ice. Upon addition of pnitrophenyl phosphate (pNPP) solution enzymatic reaction was allowed to proceed for 30 min at room temperature before optical densitiy (E 405 nm) was quantitated using ELISA plate reader. Specific binding of the antibody was calculated after substracting non-specific binding of IgG 2a -isotype(= ∆405 nm). At least three independent experiments (each performed in triplicate) were used for statistical interpretation of the data (mean value ± sd) .
RNA expression analysis (RT-PCR)
Total RNA was isolated by use of RNA Purification Kit (Sigma-Aldrich Chemie GmbH, Germany). 1µg of purified total RNA was used for RT-PCR analysis using the Titan One Tube RT-PCR System (Roche Diagnostics GmbH, Mannheim, Germany). Reverse transcription was performed at 50°C for 30min. For PCR-reaction 25 cycles were performed (denaturation: 95°C, 1min; annealing: 60°C, 2min; polymerization: 68°C, 2min). PCR products were separated onto agarose gels and DNA was visualized by ethidium bromide staining. Primers for E-selectin RNA amplification were designed according to the E-selectin mRNA sequence published (NCBI Nucleotide GenBank (accession number: NM-000450) (5'-primer: 5´-TCTCTCAGCTCTCACTTTG-3', 3´-primer: 5'-TTCTTCTTGCTGCACCTCT-3'). E-selectin PCR product is 383 bp in length. Primers for GAPDH amplification (392 bp PCR product) were as follows: 5´-primer: 5´-GTCTTCACCACCATGGAGAAGGCT-3´ and 3´-primer: 5´-CATGCCAGTGAGCTTCCCGTTCA-3´)
Cloning of the E-selectin promoter and reporter gene analysis Total genomic DNA was isolated from EA.hy-926 cells using the DNeasy TM -Tissue Kit (Qiagen GmbH, Hilden, Germany). PCR primers for cloning of the human E-selectin promoter were designed according to the E-selectin gene sequence published (Montgomery et al., PNAS USA 88 (1991)) (5'-primer: 5´-AGGCTGGTCTTGAACTCCCG-3'; 3´-primer: 5'-GACTTCAAGAGTTCTTTTCACCC-3'). After amplification by touch down PCR (30 cycles) from 66°C down to 54°C, the 1.24 kb E-selectin promoter fragment was cloned into XhoI/HindIII site of pGL3-Basic Vector (Promega Corporation, Mannheim, Germany). Succesful cloning was confirmed by sequencing. To examine transcriptional activation of the E-selectin promoter or of NF-κB minimal promoter construct (3xNF-κB-luciferase [33] subconfluent EA.hy-926 cells or HUVEC were transiently transfected with 2 µg of the corresponding construct. In case of EA.hy-926 cells, transfection was done by use of the Effectene method (Qiagen GmbH, Hilden, Germany), transfection of HUVEC was performed using ESCORT TM III Transfection Reagent (Sigma-Aldrich Fine Chemicals, Taufkirchen, Germany). 8 hours after transfection, cells were pretreated or not and stimulated after a further incubation period of 16h. About 12h after exposure, cells were harvested and luciferase activity was determined according to the manufacturers protocoll (Promega Corporation, Mannheim, Germany). Determination of protein concentration of cell extracts was done by the method of Bradford [34] . Relative luciferase activity of treated cells was related to that of untreated control which was set to 1.0. (Fig. 1A , left panel). Radiation-induced increase in the expression of E-selectin was confirmed on the level of the mRNA (data not shown) and by reporter gene analysis using a 1.24 kb human E-selectin promoter fragment which has been cloned from endothelial cell line (i.e. EA.hy-926) (Fig. 1A , right panel). Sequence analysis confirmed that the cloned E-selectin promoter is identical to that described by others [35] . Similar to HUVEC, the endothelial cell line EA.hy-926 responded to IR with a dose-dependent increase in E-selectin protein and gene expression (Fig. 1B ).
Analysis of cell adhesion
E-selectin is believed to be involved in tumor progression by promoting the adhesion of tumor cells to the endothel [26] . Therefore we wondered whether radiation treatment would lead to an increase in tumor cell adhesion. To our very best knowledge, this has not been demonstrated so far. To this end, we examined the adhesion of fluorescence-labeled colon carcinoma cells (DLD1) to a confluent layer of irradiated versus non-irradiated HUVEC. As illustrated in Fig. 2A , exposure of HUVEC to IR leads to an increased adhesion of DLD1 cells to the irradiated endothelial cell layer. Increase in tumor cell adhesion by γ-irradiation was dose dependent, becoming clearly detectable at a radiation dose of 2-5 Gy and becoming saturated at a radiation dose of 20 Gy (Fig. 2B ).
If IR-stimulated E-selectin expression is a main reason for the observed increase in tumor cell adhesion, an experimental approach to prevent this effect of radiation treatment would be to inhibit IR-induced E-selectin expression. It is known that NF-κB is required for E-selectin induction both by TNFα [36] and ionizing radiation [22] . Recently, we have shown that lovastatin, which belongs to the group of clinically highly relevant HMG-CoA reductase inhibitors, impairs UV-and doxorubicin-induced activation of NF-κB, very likely by interfering with the activity or Rho GTPases [15] . As shown here, lovastatin also blocks IRstimulated activation of NF-κB, as indicated by the reduced phosphorylation of IκBα at Ser32 (Fig. 3A) . At the same time, lovastatin largely attenuated IR-stimulated expression of Eselectin in HUVEC, which was demonstrated both on the level of the protein (by an ELISAassay) ( Fig. 3B and 3C ), the mRNA (by RT-PCR analysis) ( Fig. 3D ) and by reporter gene analysis (Fig. 3E ). Identical results were obtained using the established endothelial cell line EA.hy-926 (data not shown). The inhibitory concentration of lovastatin blocking radiationinduced E-selectin protein expression in vitro by 50 % is ~5 µM. Another HMG-CoA reductase inhibitor (i.e. simvastatin) exerted the same inhibitory effect as lovastatin (data not shown). Altogether, the data show that statins are powerful inhibitors of IR-stimulated increase in E-selectin gene and protein expression. This occurs very likely by abrogating the radiation-mediated activation of the transcription factor NF-κB. It should be noted that activation of NF-κB alone is not sufficient for stimulation of E-selectin gene expression. This is concluded from the observation that UV-C light and doxorubicin rather stimulated NF-κB-driven gene expression, as assayed by reporter gene analysis using a NF-κB minimal promoter construct (Fig. 4A ), yet these agents did not increase E-selectin expression (Fig.  4B ). Furthermore, maximal TNFα-induced E-selectin expression (obtained with high concentration of TNFα) is further increased upon exposure of the cells to IR (Fig. 4C ). The data show that the regulation of IR-induced E-selectin expression is complex and different from TNFα-stimulated E-selectin expression. Rho GTPases are reported as putative targets of statins [12] [13] [14] . Rho proteins have also been suggested to interfere with the regulation of NF-κB [37] and have been reported to potentiate TNFα-induced E-selectin expression [38] . Bearing this in mind, we examined whether specific inhibition of Rho by use of Clostridium difficile toxin A (ToxA) or by co-expression of dominant-negative Rho mimics the inhibitory effect of lovastatin on IR-stimulated Eselectin gene expression. As shown in Fig. 5 , specific inactivation of Rho GTPases using toxin A from Clostridium difficile [39, 40] largely blocked radiation-induced increase in Eselectin protein (Fig. 5A ) and gene expression (Fig. 5B) . In line with these data, co-expression of dominant-negative RhoB (N19RhoB) or Rac1 (N17Rac) inhibited the IR-induced activation of the E-selectin gene. Co-expression of dnRhoA (N19RhoA) had no effect (Fig.  5C ). Based on these findings, we suggest that Rho proteins, in particular Rac1 and RhoB, are essential for E-selectin gene induction upon exposure of endothelial cells to IR.
Retinoic acid has been reported to interfere with NF-κB signaling [41, 42] and other stressinducible transcription factors such as AP-1 [43] . As shown in Fig. 6A , all-trans retinoic acid (at-RA) efficiently blocks radiation-induced activation of NF-κB as analyzed by reporter gene assays. As opposed to at-RA, 9cis-retinoic acid (9c-RA) was not effective (Fig. 6A ).
Investigating the effect of retinoic acid on E-selectin gene expression, we observed that at-RA abrogated IR-induced E-selectin gene and protein expression, both in HUVEC and EA.hy-926 cells ( Fig. 6B and 6C ). Under identical experimental conditions 9c-RA had no effect ( Fig. 6B and 6C). It should be noted that none of the retinoic acid derivatives used affected the basal level of E-selectin gene expression (Fig. 6C) . Overall, the data show that the efficiency of different retinoic acid isomers to inhibit NF-κB activation after exposure to ionizing radiation is paralleled by a blockage of IR-induced E-selectin gene and protein expression. We would like to note that ionizing radiation did not up-regulated P-selectin protein expresssion (data not shown). Furthermore, in contrast to E-selectin expression, radiation-induced ICAM-1 protein expression was only marginally attenuated by lovastatin or at-RA (Fig. 7) . This finding indicates that the inhibitory effect of lovastatin and at-RA is specific for the cell adhesion molecule E-selectin.
Having identified lovastatin and at-RA as highly efficient inhibitors of E-selectin expression after exposure of endothelial cells to ionizing radiation, the question arises as to whether inhibition of E-selectin expression by these agents is sufficient to attenuate the adhesion of human tumour cells. As shown in Fig. 8 , pretreatment of HUVEC with either lovastatin or at-RA did not significantly affect the basal level of tumor cell adhesion. Yet, both compounds strongly reduced the radiation-provoked ~4-fold increase in the adhesion of colon carcinoma cells to HUVEC (Fig. 8A, 8B ). In contrast, 9c-RA did not significantly affect tumor cell adhesion (Fig. 8B) . The inhibitory effect of lovastatin on IR-induced tumor cell adhesion was dose-dependent, with 1 µM of lovastatin being already effective (Fig. 8C) . Regarding the inhibitory potency of at-RA, concentration of 1 µM reduced tumor cell adhesion by >50 % (Fig. 8D) . If lovastatin and at-RA were applied simultaneously at a submaximal effective dose, additive effects were observed (Fig. 9) . Thus, radiation-stimulated E-selectin protein expression (Fig. 9A) as well as tumor cell adhesion (Fig. 9B) were completely blocked by lovastatin/at-RA combination treatment. Overall, the data show that abrogation of IR-induced E-selectin expression by two different types of drugs (i.e. lovastatin and at-RA) is accompanied by a decrease in the adhesion of tumor cells to endothelial cells. This indicates that radiation-stimulated E-selectin induction is a main reason for elevated tumor cell adhesion observed after exposure of human endothelial cells to ionizing radiation.
DISCUSSION
In the present study we investigated the effect of ionizing radiation (IR) on the expression of the cell adhesion molecule E-selectin and on tumor cell adhesion to the endothel. As shown on the levels of the protein, mRNA and the promoter, γ-irradiation increases E-selectin expression in the endothelial cell line EA.hy-926 as well as in primary human umbilical vein endothelial cells (HUVEC). Radiation-stimulated E-selectin expression was observed even at a low, therapeutically relevant dose of 2 Gy, confirming an earlier report [44] . Radiationinduced E-selectin expression was paralleled by an increase in the adhesion of human colon carcinoma cells to HUVEC. So far, radiation-provoked effects on the expression of cell adhesion molecules were studied only in the context of inflammation and adhesion of leukocytes [21, 24, 45] . This is because inflammation is a well known severe side effect to radiation therapy [46] [47] [48] . Our observation of an IR-triggered increase in tumor cell adhesion points to another not yet reported unwished side effect of radiation therapy which might promote the extravasation of circulating tumor cells.
A possible strategy for avoiding these side effects of radiation therapy would be the pharmacological inhibition of radiation-induced expression of E-selectin. Regarding the regulation of the E-selectin gene, NF-κB is known to be essential for its transcriptional activation both by γ-rays and the inflammatory cytokine TNFα [22, 35, 36, 49] . Recently we found that UV-C-and doxorubicin-induced activation of NF-κB is blocked by the HMG-CoA reductase inhibitor lovastatin [15] . By measuring Ser32 phosphorylation of IκBα, we were able to confirm the hypothesis that lovastatin also attenuates activation of NF-κB by IR. In line with this, we observed that lovastatin largely blocks IR-induced expression of the Eselectin gene. As can be expected under these conditions, E-selectin protein expression was also blocked. Although UV-C light and doxorubicin activated NF-κB very efficiently, these agents did not augment E-selectin expression. This indicates that activation of NF-κB is rather a necessary but not sufficient component for E-selectin induction by ΙR. Thus, the regulation of E-selectin gene expression upon exposure of endothelial cells to TNFα or IR is obviously different.
Addressing the question as to the molecular mechanisms underlying radiation-induced Eselectin expression and its inhibition by lovastatin, we analyzed whether Rho GTPases are involved. We focused on Rho GTPases because these isoprenylated regulatory proteins are reported as targets for statins [12, 13, 15, 50] and furthermore are described to be involved in the regulation of NF-κB [37] and to potentiate E-selectin expression upon TNFα exposure [38] . We observed that pretreatment of endothelial cells with Clostridium difficile toxin A, which causes specific inactivation of Rho GTPases [39, 40] , abrogated E-selectin gene and protein induction provoked by γ-irradiation. Furthermore, as analyzed by reporter gene assays, co-expression of dominant-negative RhoB (N19RhoB) and Rac1 (N17Rac), but not of RhoA (N19RhoA), also abrogated radiation-induced increase in E-selectin gene expression. It is important to note that the basal level of E-selectin expression was neither affected by toxin A nor by expression of dnRho GPTases. Althogether, these data show that Rho GTPases, in particular RhoB and Rac1, are essential for radiation-stimulated increase in the expression of the E-selectin gene. This has not been demonstrated before. In a previous report we showed that also the TNFα-triggered E-selectin gene and protein expression is impaired by statins as well as by co-expression of dominant-negative RhoA [51] . As opposed to IR, TNFα-induced E-selectin expression was inhibited by dnRhoA [51] , supporting the hypothesis that the Besides lovastatin, we also investigated the influence of retinoic acid derivatives on E-selectin induction by IR, since retinoic acid receptors are known to exert pleiotropic effects on stressinduced gene expression [52] . We observed that at-RA efficiently abrogates E-selectin expression by IR. 9c-RA had no effect. Interestingly, stimulation of E-selectin expression by TNFα was sensitive to 9c-RA (data not shown), which is in line with another report [53] , whereas at-RA had no effect (data not shown). The different efficiencies of 9c-RA and at-RA to inhibit TNFα and IR-induced E-selectin expression, respectively, supports the view that the mechanisms involved in the regulation of E-selectin gene expression by inflammatory cytokines and ionizing radiation are different. It is known that at-RA acts as a specific ligand for nuclear RAR receptor whereas 9c-RA additionally binds to RXR type receptors [54, 55] .
Bearing this in mind, we suggest that RAR interferes with IR-induced E-selectin gene expression, whereas RXR specifically interacts with E-selectin induction stimulated by TNFα. Previously, an inhibitory effect of retinoic acid has been reported on NF-κB-dependent iNOS expression provoked by cytokine treatment, although the molecular mechanism remained unclear [56] . Recent data indicate that the inhibitory effect of retinoic acid derivatives on NF-κB signaling might be due to their direct interference with IKK, independent from RAR-receptors [57] . On the other hand, at-RA has been described to interfere also with AP-1 dependent gene expression [43, 58, 59] . Since, in addition to an NF-κB binding site, the E-selectin promoter also contains an AP-1 binding element, it appears possible that at-RA-mediated inhibition of radiation-induced AP-1 activation is partially involved in the observed attenuation of E-selectin expression. Thus, although reduction in radiation-stimulated increase in E-selectin expression by at-RA can be assumed to be due to inhibition of NF-κB and/or AP-1, the exact mechanisms involved remain to be determined and will be subject of forthcoming studies.
Having shown that lovastatin and at-RA impair IR-induced E-selectin expression, the question remained to be answered was whether inhibition of E-selectin expression is sufficient to reduce IR-stimulated tumor cell adhesion. The data obtained show that this is indeed the case. If applied at higher doses, lovastatin (10 µM) and at-RA (2 µM) reduced IRstimulated tumor cell adhesion by 70-90 %. 9c-RA neither affected E-selectin expression nor tumor cell adhesion. Thus, inhibition of IR-induced E-selectin expression was paralleled by a reduced adhesion of tumor cells to the endothel. Combined treatment with lovastatin (10 µM) and at-RA (1 µM) completely blocked both E-selectin expression and tumor cell adhesion. Notably, lovastatin and at-RA exerted only marginal inhibitory effects on radiation-induced ICAM-1 expression. Thus, together with published data [26], our findings support the view that, upon irradiation of human endothelial cells, it is mainly the induction of E-selectin which contributes to a rise in the adhesion of DLD1 cells. This hypothesis gains further support by our recent observation that lovastatin also attenuates TNFα-driven E-selectin expression and tumor cell adhesion without affecting ICAM-1 induction [51] . Of course, despite of all this evidence, we can not completely rule out the possibility that other radiation-inducible factors, which exert similar functions as E-selectin and are also sensitive to statins and at-RA, but not to 9c-RA, additionally contribute to tumor cell adhesion provoked by radiation treatment.
We also observed a radiation stimulated increase in the adhesion of mammary carcinoma cells (MCF-7) to HUVEC which could also be blocked by lovastatin (data not shown). Yet, it should be noted that adhesion of MCF-7 cells to HUVEC is much weaker (about 50 %) than that observed for DLD1 cells (data not shown). This finding is in line with previous report suggesting that sLewX is not majorly involved in endothelial adhesion of MCF-7 cells [62] . There is evidence that the basal expression of E-selectin might be enhanced in tumor cells, in particular in prostate cancer cells [63] . With respect to DLD1 cells, we detected only a very low basal level of E-selectin protein expression, which was slightly below that of nonstimulated HUVEC (data not shown). E-selectin expression in DLD1 cells was found to be inducible by ~2-fold upon irradiation (data not shown). Yet, noteworthy, this is a very weak effect as compared to the ~20-fold increase of E-selectin expression observed after exposure of HUVEC. Further, it should be noted that cellular responses on the level of tumor cells, which might influence their adhesive properties, are not relevant in our experimental setting, since we exculsively irradiated HUVEC. Nevertheless, bearing in mind that under therpeutic conditions in man both endothelial and tumor cells will be exposed to γ-rays, it will be an important subject of our future studies to characterize radiation-inducible tumor cell specific functions promoting cell-cell adhesion.
Statins have recently been reported to inhibit metastasis in vivo (i.e. in mouse xenograft system) [64, 65] , therefore being suggested as anti-tumor drugs [66] . Our data support this view, suggesting that inhbition of E-selectin-mediated tumor cell adhesion contributes to their anti-metastatic potency. HMG-CoA reductase inhibitors are clinically well established and frequently used drugs in the therapy of hypercholesterolemia. They are also reported to show anti-inflammatory effects [67] [68] [69] . It is tempting to speculate that inhibition of cytokinetriggered E-selectin expression by statins, leading to a reduced adhesion of leukocytes, might be involved here. Thus, it would be an interesting topic of forthcoming studies to analyze whether statins might be useful to soften cytokine-and radiation-induced inflammatory reactions.
Overall, our data indicate that radiation therapy might bear the potential to promote metastasis by upregulation of Rho-regulated E-selectin expression and subsequent increase in tumor cell adhesion. This unwished side effect might be alleviated by statins and at-RA. The findings provide a firm basis for future in vivo studies and clinical trials to elucidate the clinical impact of the data. Montgomery, K.F., Osborn, L., Hession, C., Tizard, R., Goff, D., Vassallo, C., Tarr To analyze the effect of IR on Eselectin gene expression, cells were transfected with E-selectin promoter luciferase construct and exposed to different doses of IR 24h later. After overnight incubation, luciferase activity was determined (right panels). Luciferase activity in the untreated control was set to 1.0. Data shown are mean values ± sd from at least three independent experiments each performed in duplicate.
Fig. 2: Ionizing radiation increases the adhesion of DLD1 cells to HUVEC.
Human Endothelial cells (HUVEC) were exposed to different doses of γ-rays. Five hours after exposure, adhesion of fluorescent-labeled DLD1 cells to HUVEC was quantitated as described in Methods. Relative cell adhesion in non-irradiated cells was set to 1.0. Data shown under B are the mean ± sd from three independent experiments each performed in quadruplicate. Photograph shown under A illustrates the stimulating effect of radiation (10 Gy) on tumor cell adhesion.
Fig. 3: IR-induced E-selectin protein and gene expression is blocked by lovastatin.
A: 15 min after radiation treatment (20 Gy) of lovastatin pretreated (Lova) (20 µM) or nonpretreated HUVEC (Con), phosphorylation status of IκBα was analyzed by use of phosphospecific antibody (Ser32). Phosphorylation of IκBα at this position is related to activation of NF-κB. For control, filter was reprobed with IκBα and ERK2 specific antibody. B: HUVEC were pretreated or not (Con) overnight with different concentration of lovastatin. Five hours after irradiation (10 Gy) cells were harvested and E-selectin protein expression was determined by ELISA as described in Methods. Data shown are mean values ± sd from at least independent experiments each performed in triplicate C: HUVEC were pretreated or not (Con) overnight with 20 µM of lovastatin. Afterwards cells were irradiated (2 Gy). Five hours after exposure cells were harvested and E-selectin protein expression was determined by ELISA as described in Methods. Data shown are mean values ± sd from three independent experiments each performed in triplicate. D: HUVEC were pretreated with lovastatin (20 µM) and were irradiated (20 Gy) as described under B. 45 min after radiation treatment RNA was isolated and E-selectin mRNA expression was analyzed by semiquantitative RT-PCR method using GAPDH as internal control. Shown is the etidiumbromide stained gel. E: 24h after transfection of HUVEC with E-selectin promoter luciferase construct cells were pretreated overnight with lovastatin (20 µM) before radiation treatment (2 Gy). Cells were harvested for determination of luciferase activity 12h later. Data shown are mean values ± sd from at least two independent experiments. .
Fig. 4: Activation of NF-B is not sufficient for stimulation of E-selectin expression.
A: EA.hy-926 endothelial cells were transfected with NF-κB specific reporter gene construct (3xNF-κB-Luciferase). 24h after transfection cells were treated with TNFα (1 ng/ml), IR (10 Gy), UV-C-light (40 J/m2) and doxorubicin (3 µM). After overnight incubation, cells were harvested and luciferase activity was determined. Data shown are the mean ± sd from three independent experiments each performed in duplicate.
B: EA.hy-926 endothelial cells were exposed to TNFα (1 ng/ml), IR (10 Gy), UV-C-light (40 J/m2) and doxorubicin (3 µM). 5h after exposure cells were harvested for determination of Eselectin expression by ELISA-based method as described. Data shown are mean values ± sd from three independent experiments each performed in triplicate. C: Subconfluent HUVEC were exposed to increasing concentration TNFα. Immediately afterwards, cells were irradiated or not with 2 Gy. After incubation period of 5 h, E-selectin expression was analyzed by ELISA. Data shown are the mean ± sd from two independent experiments each performed in triplicate. A: Human endothelial cells (HUVEC) were left untreated (Con) or were pretreated overnight with Rho-inactivating clostridial Toxin A (175ng/ml). After pretreatment period cells were exposed to γ-rays (2 Gy). Five hours after exposure, cells were harvested for analysis of Eselectin expression by ELISA-based method described in Methods. Data shown are mean values ± sd from at least three independent experiments each performed in triplicate. B: 24h after transfection of EA.hy-926 cells with E-selectin promoter luciferase construct, cells were pretreated or not (Con) with ToxA (175 ng/ml), which specifically inactivates small GTPases of the Rho family [39, 40] . Thereafter, cells were stimulated with IR (10 Gy). After overnight incubation, cells were harvested for determination of luciferase activity. Data shown are mean values ± sd from at least three independent experiments each performed in triplicate. Identical results were obtained using HUVEC (not shown). C: Endothelial cells (HUVEC) were transfected with E-selectin promoter luciferase construct together or without expression construct coding for the dominant-negative Rho GTPase RhoA (dnRhoA), RhoB (dnRhoB) and Rac1 (dnRac). After overnight incubation, cells were irradiated with a low, therapeutically relevant dose (2 Gy). After further incubation period of 18h cells were harvested for determination of luciferase activity. Relative luciferase activity in untreated control was set to 1.0. Data shown are mean values ± sd from at least two independent experiments each performed in duplicate. Con, not transfected with dnRho forms. A: 24h after transfection of HUVEC with NF-κB minimal promoter construct cells were exposed to different doses of γ-rays. 9-cis retinoic acid (9c-RA, 2 µM) and all-trans retinoic acid (at-RA, 2 µM) was added immediately after radiation treatment. After incubation period of ~16h (overnight), cells were harvested for determination of luciferase activity. Data shown are the mean ± sd from three independent experiments each performed in duplicate. B: 9-cis retinoic acid (9c-RA, 2 µM) and all-trans retinoic acid (at-RA, 2 µM) were added immediately after irradiation of HUVEC (2 Gy) or EA.hy-926 (10 Gy) (HUVEC and EA.hy-926 were exposed to different doses because they differently respond to radiation (see dose response analysis shown in Fig. 1 ). Five hours after exposure, cells were harvested for analysis of E-selectin expression by ELISA-based method as described. Data shown are mean values ± sd from at least three independent experiments each performed in triplicate. C: 24 h after transfection of endothelial cells with E-selectin promoter construct, 9-cis retinoic acid (9c-RA, 2 µM) and all-trans retinoic acid (at-RA, 2 µM) were added. Immediately after addition of retinoic acid derivatives, cells were irradiated (HUVEC (2 Gy), EA.hy-926 (10 Gy)). After overnight incubation, cells were harvested for analysis of luciferase activity, which was set to 1.0 in the non-irradiated controls. Data shown are mean values ± sd from at least two independent experiments each performed in duplicate. Human endothelial cells (HUVEC) were pretreated or not with lovastatin (10 µM, overnight). At-RA (2 µM) was added immediately after radiation treatment. Five hours after irradiation (10 Gy), E-selectin and ICAM-1 protein expresssion were analyzed by ELISA as described in Methods. Data shown are mean values ± sd from one representative experiment performed in triplicate. 
